Skip to main content

Polysaccharides as Nanocarriers for Therapeutic Applications

Buy Article:

$107.14 + tax (Refund Policy)

Nanocarriers have shown tremendous potential for the target-specific delivery of proteins, genes and drugs. Nanoparticles are fabricated using different natural and synthetic polymers. Natural polysaccharides are often used as building block for developing nano-sized drug delivery vehicles. The physicochemical properties of these materials, such as excellent biocompatibility, low cytotoxicity, surface charges that interact with DNA, protein and RNA, and cost effectiveness, make them exceptional base materials for nanocarrier fabrication. The mechanism for the complex formation of polysaccharides-DNA includes the electrostatic interactions between cationic polymers and anionic DNA to form polyplexes that offer unique possibilities for overcoming cellular barriers by escaping endosomal trafficking followed by cellular internalization and, consequently, enhancing the efficacy of drug and macromolecule delivery to targeted cells and tissue. Depending upon the cellular uptake and trafficking, nanocarriers are designed for different pharmacological and therapeutic applications. However, specific targeting that improves delivery remains an unsolved challenged. The process by which nanocarriers enter cells has important consequences not only for fate of these particles but also for biological systems and therapeutic applications.

Keywords: CELLULAR INTERNALIZATION; CLATHRIN; INTRACELLULAR TRAFFICKING; NANOCARRIERS; POLYSACCHARIDES

Document Type: Review Article

Publication date: 01 September 2014

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content